Table 1.
Baseline characteristics of patients in different groups on admission
| VZV encephalitis/meningitis group (n=32) | Herpes zoster group (n=129) | Control group (n=31) | F/χ2 | P | |
|---|---|---|---|---|---|
| Age (mean ± SD) (years) | 54.1±17.6 | 59.9±14.7 | 58.6±19.4 | 1.67 | 0.19 |
| Gender | |||||
| Male (numbers, %) | 22 (68.7%) | 63 (48.8%) | 20 (64.5%) | 5.54 | 0.06 |
| Female (numbers, %) | 10 (31.3%) | 66 (51.2%) | 11 (35.5%) | ||
| Comorbidity (cases) | |||||
| Coronary heart disease | 3 | 7 | 4 | 2.31 | 0.31 |
| COPD | 2 | 2 | 2 | 3.22 | 0.20 |
| Hypertension | 10 | 23 | 13 | 5.81 | 0.06 |
| Immune diseases | 6 | 10 | 1 | 5.29 | 0.07 |
| Use of immune drugs | 4 | 4 | 1 | 5.25 | 0.07 |
| Stroke | 2 | 6 | 5 | 5.23 | 0.07 |
| Diabetes | 6 | 9 | 4 | 4.36 | 0.11 |
| Chronic kidney disease | 1 | 5 | 3 | 2.09 | 0.35 |
| Chronic liver disease | 5 | 6 | 2 | 4.90 | 0.09 |
| Tumor | 2 | 12 | 1 | 1.41 | 0.49 |
| Herpes zoster site (numbers) | |||||
| Head and face | 22 | 91 | NA | 0.04 | 0.84 |
| Neck | 3 | 3 | NA | 3.55 | 0.06 |
| Chest and back | 7 | 20 | NA | 0.75 | 0.39 |
| Waist | 1 | 16 | NA | 2.33 | 0.13 |
| Limb | 1 | 6 | NA | 0.14 | 0.70 |
Note: NA: Not Applicable; VZV: Varicella-Zoster Virus; COPD: Chronic Obstructive Pulmonary Disease.